Resistance Exercise for Type 1 Diabetes
(FLEX-T1D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Improvements in diabetes care and technology have led to people with type 1 diabetes living longer. There are now more seniors than ever living with this complex health condition. With aging, type 1 diabetes affects both bone (more brittle), and muscle (loss of size and strength). This loss happens faster and to a greater extent in females than in males, and greatly increases the risk of frailty and falls. It may also occur more quickly in individuals who have higher blood glucose (sugar) levels.
Frailty is an important factor to address. In older females, even mild frailty decreases the ability to perform day-to-day tasks, and increases the risk of fractures, falls, hospitalization, and even death. Performing regular exercise helps to maintain the strength and quality of both muscles and bones with aging. The best type of exercise to help maintain the ability to perform activities of daily living (known as functional mobility) for this population is currently unknown. Resistance exercise (weightlifting) helps to prevent decreases in mobility in seniors without diabetes. However, in the context of type 1 diabetes, high blood sugar levels could negatively impact these potential strength benefits and low blood glucose could lead to falls. As such, any exercise program that causes swings in glucose levels may hinder rather than help.
The goal of this study is to evaluate the effect of weightlifting over a 6-month timeframe on functional mobility in postmenopausal females with type 1 diabetes, compared to a group that does not train. the investigators will also assess its effects on blood sugar variability and the risk of hypoglycemia. Like different medications, not all exercise is equal. Creating more knowledge about the benefits of specific types of exercise in this population will allow us to be more precise in our exercise recommendations for living longer and more independently with type 1 diabetes.
Who Is on the Research Team?
Jane E Yardley, PhD
Principal Investigator
Institut de Recherches Cliniques de Montreal
Are You a Good Fit for This Trial?
This trial is for postmenopausal women who have type 1 diabetes. Participants should be older adults living with this condition and able to safely take part in an exercise program.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Resistance exercise
Trial Overview
The study tests whether a regular weightlifting (resistance exercise) program over six months can improve movement, strength, and blood sugar control compared to not exercising in postmenopausal women with type 1 diabetes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Supervised progressive resistance exercise training three times weekly
Usual care. Participants will be offered the training program at the end of the 6-month control period.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Institut de Recherches Cliniques de Montreal
Lead Sponsor
McMaster University
Collaborator
University of Alberta
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.